Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.

Acta ophthalmologica Scandinavica - 1 Dec 1999

Kalayci D, Gürgey A, Güven D, Parlak H, Hasiripi H

Abstract excerpt

PURPOSE: The role of factor V Leiden and prothrombin 20210 A mutations has been investigated in patients with central retinal vein occlusion (CRVO), hemispheric retinal vein occlusion (HRVO), and branch retinal vein occlusion (BRVO). METHODS: Factor V Leiden and prothrombin 20210 A were investiga...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to DNA
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Point Mutation

Share to Prothrombin

Share to Retinal Vein Occlusion

Share to Risk Factors

Source

Identifiers

PMID: 10634550
DOI: 10.1034/j.1600-0420.1999.770602.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10634550-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion.PMID 10634550Read ↗

Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.Semantic proximity Read ↗

The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study.Semantic proximity Read ↗

Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.Semantic proximity Read ↗

Branch retinal vein occlusion associated with the 20210 G-to-A prothrombin variant.Semantic proximity Read ↗

Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.Semantic proximity Read ↗

Thrombophilic mutations and risk of retinal vein occlusion.Semantic proximity Read ↗

Genetic thrombophilia in patients with retinal vascular occlusion.Semantic proximity Read ↗

Thrombophilia in patients with retinal vein occlusion: a retrospective analysis.Semantic proximity Read ↗

Idiopathic central retinal vein occlusion in 2 siblings with the 20210 G-->A prothrombin variant.Semantic proximity Read ↗

The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.Semantic proximity Read ↗

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.Semantic proximity Read ↗

Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.